Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

724 ARTÍCULOS , VIENDO DEL 646 AL 660

Transforming Pediatric Movement Disorders Assessment: From Expert Consensus to Collaborative Approaches

Gimeno H, Desjardins C, Nilles C, Peall KJ, Martino D, Pringsheim T, Roze E.

Mov Disord. 2026 Jan;41(1):286-287. doi: 10.1002/mds.70163. Epub 2025 Dec 22.

Polysomnography and Autonomic Function Signatures of Nocturnal Enuresis: An Observational Study

Thosare P, Chakrabarty B, Gulati S, Jariyal A, Hari P, Jauhari P, Kabra S, Sikka K, Pandey RM, Dutt Upadhyay A, Khan S.

Pediatr Neurol. 2026 Feb;175:102-107. doi: 10.1016/j.pediatrneurol.2025.11.003. Epub 2025 Nov 8.

Deep brain stimulation in patients with mixed movement disorders linked to ADCY5

Retailleau E, Dorison N, Poulen G, Roubertie A, Trouillard O, Baik J, Conabady E, François-Heude MC, Chauvet-Piat E, Spitz MA, Ravelli C, Vayssière P, Nilles C, Desjardins C, Dubacq C, Roze E.

Rev Neurol (Paris). 2026 Mar;182(3):113-119. doi: 10.1016/j.neurol.2025.12.003. Epub 2025 Dec 26.

A Comparative Study of Polysomnography-Derived Sleep Disturbance in People Living With Multiple Sclerosis Compared to Matched Controls From the General Population

Reynolds AC, Thomas E, Melaku YA, Hensen HA, Krishnan AV, Gandevia SC, Lord SR, Eastwood PR, Eckert DJ.

J Sleep Res. 2026 Feb;35(1):e70075. doi: 10.1111/jsr.70075. Epub 2025 Apr 28.

Movement disorders rounds: Neurophysiological findings in abdominal movements in CASPR2 encephalitis

Grippe T, Abkur T, Lin YY, Shafa G, Rastogi A, Chen R, Kalia LV.

Parkinsonism Relat Disord. 2026 Jan;142:107998. doi: 10.1016/j.parkreldis.2025.107998. Epub 2025 Aug 19.

Immature ovarian teratomas in anti-NMDA receptor encephalitis

Simone K, Nathoo N, Hooper A, Aboseif A, Buletko AB, Satkunam N, McCombe JA, Pin S.

J Neuroimmunol. 2026 Mar;412:578850. doi: 10.1016/j.jneuroim.2025.578850. Epub 2025 Dec 26.

A review of treatment methods for movement disorders

Khezri M, Afsar S.

Behav Brain Res. 2026 Mar 5;500:115979. doi: 10.1016/j.bbr.2025.115979. Epub 2025 Dec 4.

Clinical neurophysiology in movement disorders: toward integration into systems-based practice

Lizarraga KJ, Chen R.

Clin Neurophysiol. 2026 Mar;183:2111480. doi: 10.1016/j.clinph.2025.2111480. Epub 2025 Dec 16.

The Influence of Videography in the Foundation and Future of Movement Disorders

Rosso M, Chu D, Barton B.

Mov Disord Clin Pract. 2026 Feb;13(2):359-368. doi: 10.1002/mdc3.70299. Epub 2025 Aug 26.

The Role of AI in the Management of Movement Disorders

Deik A.

Semin Neurol. 2026 Feb;46(1):77-85. doi: 10.1055/a-2596-5950. Epub 2025 Apr 29.

Parkinson's Disease Multidisciplinary Complex Therapy (PD-MCT): appreciation of its current function for the treatment of people with Parkinson's disease in Germany and the needs of future development

Scherbaum R, Höllerhage M, Klebe S, Riederer P, Müller T, Schröter N, Weise D, Woitalla D, Tönges L.

J Neural Transm (Vienna). 2026 Feb;133(2):335-345. doi: 10.1007/s00702-025-02963-7. Epub 2025 Jun 12.

Characteristics and Validity of Commercially Available Technologies Analyzing Voice Features to Assess Parkinson's Disease

Dean JM, Iankova V, Roberts A, Schneider SA.

Mov Disord Clin Pract. 2026 Jan;13(1):60-70. doi: 10.1002/mdc3.70214. Epub 2025 Jul 11.

Comparison of levodopa response rate in association with clinical features in Parkinson's disease subjects with and without STN-DBS

Onder H, Comoglu S.

Neurol Res. 2026 May;48(5):576-585. doi: 10.1080/01616412.2025.2537897. Epub 2025 Jul 21.

Efficacy and Safety of Foslevodopa/Foscarbidopa Monotherapy in Patients with Parkinson's Disease

Aldred J, Bouchard M, Martínez-Castrillo JC, Soileau MJ, Spiegel AM, Bergmann L, Gupta R, Shah MB, Kukreja P, Standaert DG, Isaacson SH, Henriksen T.

Mov Disord Clin Pract. 2026 Jan;13(1):181-190. doi: 10.1002/mdc3.70245. Epub 2025 Jul 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias